Monitoring Malaria Treatment in the United States

Program Description: To collect, manage and analyze data on the safety and efficacy of tafenoquine (Krintafel) used for anti-relapse therapy of malaria in the United States.
Funding Partners:
  • GlaxoSmithKline Biologicals S.A.
Program Partners:
  • CDC’s Center for Global Health
Program Location:
  • United States of America